MONOCLONAL ANTIBODY RECOGNIZING HUMAN ABL2  
UCLA Technology Available For Licensing

INNOVATION:  Researchers at UCLA have developed a monoclonal antibody that recognizes the human ABL2 (Abelson murine leukemia viral oncogene homolog 2) protein. It has been successfully used in standard immunoblot and immuno-precipitation techniques.

Related Papers (Selected)

Reference: UCLA Case No. 2009-010

For additional technical details and current licensing
availability, please contact the following UCLA office:

UCLA Office of Intellectual Property
11000 Kinross Avenue, Suite #200
Los Angeles, CA 90095
Tel: 310-794-0558 Fax: 310-794-0638
email: ncd@research.ucla.edu
NCD URL:   http://www.research.ucla.edu/tech/ucla09-010.htm

Lead Inventor: John Colicelli

UCLA Technologies Available for Licensing
http://www.research.ucla.edu/oipa/industry

Copyright © 2008 The Regents of the University of California.

keywords: antibody, monoclonal, ABL2, Abelson murine leukemia viral oncogene homolog 2 uclancd ucla latest inventions technology top ten 10 technologies intellectual property patents technology transfer invention business card